Translation and Validation of MPCOSQ in Urdu Language

• All statistical analyses will be conducted using the Statistical Product and Service Solution version 21 software.
• Continuous variables will be shown by mean and standard deviation and the categories will be demonstrated in frequency and percentage.
• In this study, factor structure of the (MPCOQ) will be analyzed using the principal component factor analysis with varimax rotation.
• Intraclass Correlation Coefficient (ICC) (95% confidence interval) will be used for test-retest value and Cronbach's Alpha will be used for internal consistency analysis.
• Measurement error will be determined by calculating the standard error of measurement (SEM) and the Smallest Detectable Change (SDC). Independent t-test will be used to determine the differences between groups

Inclusion criteria

• • Age 18 - 30

• Married
• Female patients diagnosed with PCOS, having 2 of the following Rotterdam diagnostic criteria:

I. Polycystic ovaries visualized on ultrasound scan (presence of 12 follicles or more in one or both ovaries and/or increased ovarian volume >10ml II. Clinical signs of hyperandrogenism (the hirsutism score based on the Ferriman-Gallwey score >7 or obvious acne) III. Having an interval between menstrual periods >35 days and/or amenorrhea as the absence of vaginal bleeding for at least 6 months, i.e. 199 days Patients who are willing to participate

Exclusion criteria

• • Non-adrenal hyperplasia, thyroid dysfunction, and hyperprolactinemia

• Female undergoing Hormone Replacement Therapy
• Female with malignancies
• Any recent fractures, surgeries
• Patient with nephrological and neurological conditions
• Dementia or cognitive impairments